Role of chemotherapy of taeniasis in prevention of neurocysticercosis

Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key intervention in preventing NC is elimination of taeniasis by chemotherapy. Currently, two safe and effective taenicides, namely niclosamide and praziqua...

Full description

Saved in:
Bibliographic Details
Published inParasitology international Vol. 55; pp. S105 - S109
Main Author Pawlowski, Zbigniew S.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ireland Ltd 01.01.2006
Subjects
Animals
Anticestodal Agents - therapeutic use
Chemotherapy
Control measures
Cysticercus
Humans
Neurocysticercosis
Neurocysticercosis - prevention & control
Niclosamide - therapeutic use
Praziquantel - therapeutic use
Taenia
Taenia solium
Taenia solium - drug effects
Taenia solium - growth & development
Taeniasis - drug therapy
Taeniasis - parasitology
Control measures
Chemotherapy
Neurocysticercosis
Taenia solium
Online AccessGet full text

Cover

Abstract Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key intervention in preventing NC is elimination of taeniasis by chemotherapy. Currently, two safe and effective taenicides, namely niclosamide and praziquantel, are available. Both are on WHO Essential Drug list, but are often inaccessible in T. solium endemic areas. Natural remedies, still widely used in some endemic areas, are frequently carcinogenic or highly toxic and as such should be discontinued. Chemotherapeutic intervention to control T. solium taeniasis/cysticercosis, whilst theoretically feasible, has several practical obstacles. These include poor public awareness, problems with diagnosing Taenia carriers, poor availability of taenicides where needed and low priority afforded to the control of NC. These can be overcome, respectively, by effective health education, wider use of newly developed coproantigen tests, strengthening of health services infrastructure and essential drugs distribution, and increasing the priority given to prevention of NC, as a leading cause of epilepsy in T. solium endemic areas. Information is accumulating on rational approaches to population-based short-term chemotherapeutic control measures. These are: widely available modern diagnostic tools and taenicides, treatment of any case of taeniasis, confirmed or probable, focus-oriented chemotherapy, irrespective of Taenia species implicated, improved sanitation, cooperation of veterinary and medical services, linkage with programs against epilepsy and cooperation of better educated communities. Now, it remains to take an advantage of existing tools and experience.
AbstractList Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key intervention in preventing NC is elimination of taeniasis by chemotherapy. Currently, two safe and effective taenicides, namely niclosamide and praziquantel, are available. Both are on WHO Essential Drug list, but are often inaccessible in T. solium endemic areas. Natural remedies, still widely used in some endemic areas, are frequently carcinogenic or highly toxic and as such should be discontinued. Chemotherapeutic intervention to control T. solium taeniasis/cysticercosis, whilst theoretically feasible, has several practical obstacles. These include poor public awareness, problems with diagnosing Taenia carriers, poor availability of taenicides where needed and low priority afforded to the control of NC. These can be overcome, respectively, by effective health education, wider use of newly developed coproantigen tests, strengthening of health services infrastructure and essential drugs distribution, and increasing the priority given to prevention of NC, as a leading cause of epilepsy in T. solium endemic areas. Information is accumulating on rational approaches to population-based short-term chemotherapeutic control measures. These are: widely available modern diagnostic tools and taenicides, treatment of any case of taeniasis, confirmed or probable, focus-oriented chemotherapy, irrespective of Taenia species implicated, improved sanitation, cooperation of veterinary and medical services, linkage with programs against epilepsy and cooperation of better educated communities. Now, it remains to take an advantage of existing tools and experience.
Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key intervention in preventing NC is elimination of taeniasis by chemotherapy. Currently, two safe and effective taenicides, namely niclosamide and praziquantel, are available. Both are on WHO Essential Drug list, but are often inaccessible in T. solium endemic areas. Natural remedies, still widely used in some endemic areas, are frequently carcinogenic or highly toxic and as such should be discontinued. Chemotherapeutic intervention to control T. solium taeniasis/cysticercosis, whilst theoretically feasible, has several practical obstacles. These include poor public awareness, problems with diagnosing Taenia carriers, poor availability of taenicides where needed and low priority afforded to the control of NC. These can be overcome, respectively, by effective health education, wider use of newly developed coproantigen tests, strengthening of health services infrastructure and essential drugs distribution, and increasing the priority given to prevention of NC, as a leading cause of epilepsy in T. solium endemic areas. Information is accumulating on rational approaches to population-based short-term chemotherapeutic control measures. These are: widely available modern diagnostic tools and taenicides, treatment of any case of taeniasis, confirmed or probable, focus-oriented chemotherapy, irrespective of Taenia species implicated, improved sanitation, cooperation of veterinary and medical services, linkage with programs against epilepsy and cooperation of better educated communities. Now, it remains to take an advantage of existing tools and experience.
Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key intervention in preventing NC is elimination of taeniasis by chemotherapy. Currently, two safe and effective taenicides, namely niclosamide and praziquantel, are available. Both are on WHO Essential Drug list, but are often inaccessible in T. solium endemic areas. Natural remedies, still widely used in some endemic areas, are frequently carcinogenic or highly toxic and as such should be discontinued. Chemotherapeutic intervention to control T. solium taeniasis/cysticercosis, whilst theoretically feasible, has several practical obstacles. These include poor public awareness, problems with diagnosing Taenia carriers, poor availability of taenicides where needed and low priority afforded to the control of NC. These can be overcome, respectively, by effective health education, wider use of newly developed coproantigen tests, strengthening of health services infrastructure and essential drugs distribution, and increasing the priority given to prevention of NC, as a leading cause of epilepsy in T. solium endemic areas. Information is accumulating on rational approaches to population-based short-term chemotherapeutic control measures. These are: widely available modern diagnostic tools and taenicides, treatment of any case of taeniasis, confirmed or probable, focus-oriented chemotherapy, irrespective of Taenia species implicated, improved sanitation, cooperation of veterinary and medical services, linkage with programs against epilepsy and cooperation of better educated communities. Now, it remains to take an advantage of existing tools and experience.
Author Pawlowski, Zbigniew S.
Author_xml – sequence: 1
  givenname: Zbigniew S.
  surname: Pawlowski
  fullname: Pawlowski, Zbigniew S.
  email: Zpawlows@am.poznan.pl
  organization: Clinic of Parasitic and Tropical Diseases, University of Medical Sciences, ul. Przybyszewskiego 49 60-355 Poznan, Poland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16356763$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1rHDEMhk1JaT7afxDCnnKbiTS2x55LIYS0CQQKpT0br0fT9TJrT-3Zhf339bJL015ykoRevZKeS3YWYiDGrhFqBGzv1vVkkw9z3QDIGrEGVO_YBWrFK-BNd1ZyrnklVduds8uc1wAolcIP7BxbLlvV8gv2-D2OtIjDwq1oE-cVJTvtD_VsKXibfV74sJgS7SjMPoZDK9A2RbfPs3eUXCyaj-z9YMdMn07xiv388vjj4al6-fb1-eH-pXIt4lwJKSWXA3JSfYNKDr1u24YIG40cehRCLoXttAUJtITySq8FUjN0RBqA-BX7fPSdtssN9a7clOxopuQ3Nu1NtN783wl-ZX7FnVEImmtRDG5PBin-3lKezcZnR-NoA8VtNtgJLkF0RSiOQpdizomGv0sQzIG_WZsjf3PgbxBN4V_Gbv498HXoBPz1AyqYdp6Syc5TcNT7RG42ffRvb_gDijabwQ
CitedBy_id crossref_primary_10_1016_j_actatropica_2016_01_013
crossref_primary_10_1016_j_trstmh_2007_10_007
crossref_primary_10_3390_pharmaceutics13101567
crossref_primary_10_4269_ajtmh_12_0355
crossref_primary_10_1645_GE_1018R1_1
crossref_primary_10_1016_j_actatropica_2007_02_002
crossref_primary_10_1111_j_1365_3024_2011_01319_x
crossref_primary_10_1016_j_trstmh_2011_08_013
crossref_primary_10_1155_2024_2550598
crossref_primary_10_1128_CMR_00085_19
crossref_primary_10_1371_journal_pntd_0001651
crossref_primary_10_3390_pathogens11101212
crossref_primary_10_1016_j_actatropica_2016_03_013
crossref_primary_10_1016_j_antinf_2012_06_002
crossref_primary_10_1017_S0031182013001157
crossref_primary_10_1017_S0031182013000966
crossref_primary_10_1016_j_meegid_2015_06_022
crossref_primary_10_1212_01_CON_0000423853_47770_90
crossref_primary_10_1179_2047773212Y_0000000047
crossref_primary_10_1186_s12879_021_06778_1
crossref_primary_10_1039_C7RA05873J
crossref_primary_10_1016_j_ijpara_2005_07_015
crossref_primary_10_4236_wjns_2016_62020
crossref_primary_10_1016_j_parint_2005_11_045
crossref_primary_10_1016_j_parint_2005_11_002
crossref_primary_10_1100_2012_159821
Cites_doi 10.1016/S0001-706X(02)00269-3
10.1016/j.mrgentox.2004.10.007
10.1016/0001-706X(90)90046-3
10.1212/01.WNL.0000142979.98182.FF
10.1016/j.pt.2004.06.004
10.1016/S0065-308X(08)60176-1
10.1086/428839
10.1016/S0001-706X(03)00064-0
10.1016/S0001-706X(03)00038-X
10.1016/0378-8741(94)01191-2
10.1016/0140-6736(93)90064-N
10.1016/0140-6736(93)91743-6
10.1016/j.bmc.2004.03.035
10.1016/S0001-706X(03)00034-2
10.1016/j.ijpara.2005.07.015
10.4269/ajtmh.1999.61.386
10.1086/313470
ContentType Journal Article
Copyright 2005 Elsevier Ireland Ltd
Copyright © 2005 Elsevier Ireland Ltd. All rights reserved. 2005 Elsevier Ireland Ltd
Copyright_xml – notice: 2005 Elsevier Ireland Ltd
– notice: Copyright © 2005 Elsevier Ireland Ltd. All rights reserved. 2005 Elsevier Ireland Ltd
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
5PM
DOI 10.1016/j.parint.2005.11.017
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Neurosciences Abstracts
DatabaseTitleList MEDLINE


Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Zoology
EISSN 1873-0329
EndPage S109
ExternalDocumentID 10_1016_j_parint_2005_11_017
16356763
S1383576905001194
Genre Journal Article
Review
GroupedDBID ---
--K
--M
-RU
.1-
.55
.FO
.~1
0R~
123
1B1
1P~
1~.
1~5
29O
4.4
457
4G.
53G
5VS
7-5
71M
8P~
AAAJQ
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AAXUO
ABBQC
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CJTIS
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LUGTX
M41
MO0
N9A
O-L
O9-
OAUVE
OD-
OO.
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSI
SSZ
T5K
UHS
UNMZH
X7M
Z5R
~G-
AAHBH
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
5PM
ID FETCH-LOGICAL-c611t-455535f13e7d2175fd8662ee128130d1445b4a98a050eb0187d841e2f9ee800e3
IEDL.DBID AIKHN
ISSN 1383-5769
IngestDate Tue Sep 17 21:26:07 EDT 2024
Fri Oct 25 08:00:18 EDT 2024
Thu Sep 26 16:10:50 EDT 2024
Sat Sep 28 08:28:38 EDT 2024
Fri Feb 23 02:24:30 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Control measures
Chemotherapy
Neurocysticercosis
Taenia solium
Language English
License Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c611t-455535f13e7d2175fd8662ee128130d1445b4a98a050eb0187d841e2f9ee800e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7108384
PMID 16356763
PQID 19435049
PQPubID 23462
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7108384
proquest_miscellaneous_19435049
crossref_primary_10_1016_j_parint_2005_11_017
pubmed_primary_16356763
elsevier_sciencedirect_doi_10_1016_j_parint_2005_11_017
PublicationCentury 2000
PublicationDate 2006-01-01
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – month: 01
  year: 2006
  text: 2006-01-01
  day: 01
PublicationDecade 2000
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Parasitology international
PublicationTitleAlternate Parasitol Int
PublicationYear 2006
Publisher Elsevier Ireland Ltd
Publisher_xml – name: Elsevier Ireland Ltd
References Bern, García, Evans, Gonzalez, Verastegui, Tsang (bib1) 1996; 29
Roman, Sotelo, Del Brutto, Flisser, Dumas, Wadia (bib28) 2000; 78
Haenel (bib9) 1950; 5
Wallin, Kurtzke (bib3) 2004; 63
Engels, Urbani, Belotto, Meslin, Savioli (bib20) 2003; 87
Sarti, Rajshekhar (bib21) 2003; 87
Cruz, Davis, Dixon, Pawłowski, Proano (bib14) 1989; 67
Gonzalez, Gilman, Garcia, Lopez (bib25) 2002
Zhang, Yap (bib12) 2004; 15
Pawłowski (bib16) 1990; 48
Schantz, Cruz, Sarti, Pawlowski (bib17) 1993; 27
Desta (bib5) 1995; 45
Jung, Gonzales-Esquivel (bib15) 2002
García-Garcia, Tores, Correa, Flisser, Sosa-Lechuga, Velasco (bib24) 1999; 61
Presentation by Mr Bill Gates. Fifty-eighth World Health Assembly, 19th May 2005, Geneva, WHO document A58/DIV/8.
Pawlowski, Allan, Sarti (bib27) 2005; 35
Allan, Craig, Pawlowski (bib19) 2002
Schantz, Wilkins, Tsang (bib2) 1998; vol. 2
Fox LeAnne, Saravolatz (bib11) 2005; 40
Pawlowski ZS, Allan JC, Meinardi H. Chapter 6. Control measures. In: Murrell KD, editor. Guidelines on taeniasis/cysticercosis. WHO, OIE, FAO, Geneva. 2005: 73–99.
Lee, Liu, Wu, Tang, Leh, Wu (bib10) 2005; 565
PAHO/WHO. PAHO/WHO Informal Consultation on the Taeniosis/Cysticercosis Complex. 23–25 August, 1995, PAHO, Washington D.C.; 1995. document HCT/AIEPI-5.
Molyneux, Hopkins, Zagaria (bib18) 2004; 20
Diop, de Boer, Mandlhate, Prilipko, Meinardi (bib30) 2003; 87
Pawlowski, Schulz (bib8) 1972; 10
Ito, Urbani, Qiu, Vuitton, Qiu, Health (bib22) 2003; 86
Gemmell, Matyas, Pawlowski, Soulsby, Larralde, Nelson (bib6) 1983
Flisser, Madrazo, Plancarte, Schantz, Allan, Craig (bib13) 1993; 342
Pawlowski (bib26) 1991; 22
Garcia, Gilman, Martinez, Tsang, Pilcher, Herrera (bib29) 1993; 341
Notter, Robert, Bertrand (bib7) 1968; 20
Diop (10.1016/j.parint.2005.11.017_bib30) 2003; 87
10.1016/j.parint.2005.11.017_bib4
Pawlowski (10.1016/j.parint.2005.11.017_bib27) 2005; 35
10.1016/j.parint.2005.11.017_bib23
Cruz (10.1016/j.parint.2005.11.017_bib14) 1989; 67
Ito (10.1016/j.parint.2005.11.017_bib22) 2003; 86
Desta (10.1016/j.parint.2005.11.017_bib5) 1995; 45
Schantz (10.1016/j.parint.2005.11.017_bib2) 1998; vol. 2
Gemmell (10.1016/j.parint.2005.11.017_bib6) 1983
Zhang (10.1016/j.parint.2005.11.017_bib12) 2004; 15
Flisser (10.1016/j.parint.2005.11.017_bib13) 1993; 342
Notter (10.1016/j.parint.2005.11.017_bib7) 1968; 20
Pawlowski (10.1016/j.parint.2005.11.017_bib26) 1991; 22
Sarti (10.1016/j.parint.2005.11.017_bib21) 2003; 87
Haenel (10.1016/j.parint.2005.11.017_bib9) 1950; 5
Garcia (10.1016/j.parint.2005.11.017_bib29) 1993; 341
Fox LeAnne (10.1016/j.parint.2005.11.017_bib11) 2005; 40
Jung (10.1016/j.parint.2005.11.017_bib15) 2002
Wallin (10.1016/j.parint.2005.11.017_bib3) 2004; 63
Roman (10.1016/j.parint.2005.11.017_bib28) 2000; 78
Lee (10.1016/j.parint.2005.11.017_bib10) 2005; 565
García-Garcia (10.1016/j.parint.2005.11.017_bib24) 1999; 61
10.1016/j.parint.2005.11.017_bib31
Pawlowski (10.1016/j.parint.2005.11.017_bib8) 1972; 10
Pawłowski (10.1016/j.parint.2005.11.017_bib16) 1990; 48
Allan (10.1016/j.parint.2005.11.017_bib19) 2002
Engels (10.1016/j.parint.2005.11.017_bib20) 2003; 87
Gonzalez (10.1016/j.parint.2005.11.017_bib25) 2002
Bern (10.1016/j.parint.2005.11.017_bib1) 1996; 29
Schantz (10.1016/j.parint.2005.11.017_bib17) 1993; 27
Molyneux (10.1016/j.parint.2005.11.017_bib18) 2004; 20
References_xml – volume: 10
  start-page: 269
  year: 1972
  end-page: 343
  ident: bib8
  article-title: Taeniasis and cysticercosis (
  publication-title: Adv Parasitol
  contributor:
    fullname: Schulz
– volume: 15
  start-page: 2517
  year: 2004
  end-page: 2521
  ident: bib12
  article-title: Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV
  publication-title: Bioorg Med Chem
  contributor:
    fullname: Yap
– volume: 78
  start-page: 399
  year: 2000
  end-page: 406
  ident: bib28
  article-title: A proposal to declare neurocysticercosis an international reportable disease
  publication-title: Bull WHO
  contributor:
    fullname: Wadia
– volume: 61
  start-page: 386
  year: 1999
  end-page: 389
  ident: bib24
  article-title: Prevalence and risk of cysticercosis and taeniasis in an urban population of soldiers and their relatives
  publication-title: Am J Trop Med Hyg
  contributor:
    fullname: Velasco
– volume: vol. 2
  start-page: 213
  year: 1998
  end-page: 242
  ident: bib2
  article-title: Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem
  publication-title: Emerging Infections
  contributor:
    fullname: Tsang
– volume: 342
  start-page: 748
  year: 1993
  ident: bib13
  article-title: Neurological symptoms in occult neurocysticercosis after a single taeniacidal dose of praziquantel
  publication-title: Lancet
  contributor:
    fullname: Craig
– volume: 40
  start-page: 1173
  year: 2005
  end-page: 1180
  ident: bib11
  article-title: Nitazoxanide: a new thiazolide antiparasitic agent
  publication-title: Clin Infect Dis
  contributor:
    fullname: Saravolatz
– volume: 87
  start-page: 177
  year: 2003
  end-page: 182
  ident: bib20
  article-title: The control of human (neuro)cysticercosis: which way forward?
  publication-title: Acta Trop
  contributor:
    fullname: Savioli
– start-page: 411
  year: 2002
  end-page: 420
  ident: bib19
  article-title: Control of
  publication-title:
  contributor:
    fullname: Pawlowski
– volume: 22
  start-page: 284
  year: 1991
  end-page: 286
  ident: bib26
  article-title: Control of
  publication-title: Southeast Asian J Trop Med Public Health
  contributor:
    fullname: Pawlowski
– volume: 20
  start-page: 319
  year: 1968
  end-page: 320
  ident: bib7
  article-title: Influence teratogene possible des taenifuges a base d'etain (Discussion de trois observations d'ectromelies)
  publication-title: Bull Fed Soc Gynecol Obstet Lang Fr
  contributor:
    fullname: Bertrand
– volume: 48
  start-page: 83
  year: 1990
  end-page: 88
  ident: bib16
  article-title: Efficacy of low doses of praziquantel in taeniasis
  publication-title: Acta Trop
  contributor:
    fullname: Pawłowski
– volume: 35
  start-page: 1221
  year: 2005
  end-page: 1232
  ident: bib27
  article-title: Control of
  publication-title: Int J Parasitol
  contributor:
    fullname: Sarti
– volume: 29
  start-page: 1203
  year: 1996
  end-page: 1209
  ident: bib1
  article-title: Magnitude of the disease burden from neurocysticercosis in a developing country
  publication-title: Curr Infect Dis
  contributor:
    fullname: Tsang
– volume: 67
  start-page: 401
  year: 1989
  end-page: 407
  ident: bib14
  article-title: Operational studies on control of
  publication-title: Bull WHO
  contributor:
    fullname: Proano
– volume: 87
  start-page: 137
  year: 2003
  end-page: 143
  ident: bib21
  article-title: Measures for the prevention and control of
  publication-title: Acta Trop
  contributor:
    fullname: Rajshekhar
– year: 1983
  ident: bib6
  article-title: Guidelines for surveillance, prevention and control of taeniasis/cysticercosis
  contributor:
    fullname: Nelson
– volume: 565
  start-page: 121
  year: 2005
  end-page: 128
  ident: bib10
  article-title: Safrole-DNA adducts in tissues from esophageal cancer patients: clues to areca-related esophageal carcinogenesis
  publication-title: Mutat Res
  contributor:
    fullname: Wu
– start-page: 437
  year: 2002
  end-page: 448
  ident: bib25
  article-title: Use of simulation model to evaluate control programmes against
  publication-title:
  contributor:
    fullname: Lopez
– volume: 45
  start-page: 27
  year: 1995
  end-page: 33
  ident: bib5
  article-title: Ethiopian traditional herbal drugs: Part I. Studies on the toxicity and therapeutic activity of local taenicidal medications
  publication-title: J Ethnopharmacol
  contributor:
    fullname: Desta
– volume: 63
  start-page: 1559
  year: 2004
  end-page: 1564
  ident: bib3
  article-title: Neurocysticercosis in the United States: review of an important emerging infection
  publication-title: Neurology
  contributor:
    fullname: Kurtzke
– volume: 341
  start-page: 197
  year: 1993
  end-page: 200
  ident: bib29
  article-title: Cysticercosis as a major cause of epilepsy in Peru
  publication-title: Lancet
  contributor:
    fullname: Herrera
– volume: 27
  start-page: 397
  year: 1993
  end-page: 403
  ident: bib17
  article-title: Potential erradicability of taeniasis and cysticercosis
  publication-title: Rev Bul Pan Am Health Org
  contributor:
    fullname: Pawlowski
– volume: 20
  start-page: 347
  year: 2004
  end-page: 351
  ident: bib18
  article-title: Disease eradication, elimination and control: the need for accurate and consistent usage
  publication-title: Trends Parasitol
  contributor:
    fullname: Zagaria
– start-page: 363
  year: 2002
  end-page: 374
  ident: bib15
  article-title: Pharmacology of anticysticercal therapy
  publication-title:
  contributor:
    fullname: Gonzales-Esquivel
– volume: 87
  start-page: 149
  year: 2003
  end-page: 159
  ident: bib30
  article-title: The global campaign against epilepsy in Africa
  publication-title: Acta Trop
  contributor:
    fullname: Meinardi
– volume: 5
  start-page: 18
  year: 1950
  end-page: 23
  ident: bib9
  article-title: Beitrag zur Toxikologie der gebrauchlichsten Anthelminthica
  publication-title: Pharmazie
  contributor:
    fullname: Haenel
– volume: 86
  start-page: 3
  year: 2003
  end-page: 17
  ident: bib22
  article-title: Control of echinococcosis and cysticercosis: a public health challenge to international cooperation in China
  publication-title: Acta Trop
  contributor:
    fullname: Health
– volume: 5
  start-page: 18
  year: 1950
  ident: 10.1016/j.parint.2005.11.017_bib9
  article-title: Beitrag zur Toxikologie der gebrauchlichsten Anthelminthica
  publication-title: Pharmazie
  contributor:
    fullname: Haenel
– volume: 86
  start-page: 3
  year: 2003
  ident: 10.1016/j.parint.2005.11.017_bib22
  article-title: Control of echinococcosis and cysticercosis: a public health challenge to international cooperation in China
  publication-title: Acta Trop
  doi: 10.1016/S0001-706X(02)00269-3
  contributor:
    fullname: Ito
– volume: 565
  start-page: 121
  year: 2005
  ident: 10.1016/j.parint.2005.11.017_bib10
  article-title: Safrole-DNA adducts in tissues from esophageal cancer patients: clues to areca-related esophageal carcinogenesis
  publication-title: Mutat Res
  doi: 10.1016/j.mrgentox.2004.10.007
  contributor:
    fullname: Lee
– volume: 48
  start-page: 83
  year: 1990
  ident: 10.1016/j.parint.2005.11.017_bib16
  article-title: Efficacy of low doses of praziquantel in taeniasis
  publication-title: Acta Trop
  doi: 10.1016/0001-706X(90)90046-3
  contributor:
    fullname: Pawłowski
– volume: 20
  start-page: 319
  year: 1968
  ident: 10.1016/j.parint.2005.11.017_bib7
  article-title: Influence teratogene possible des taenifuges a base d'etain (Discussion de trois observations d'ectromelies)
  publication-title: Bull Fed Soc Gynecol Obstet Lang Fr
  contributor:
    fullname: Notter
– volume: 78
  start-page: 399
  year: 2000
  ident: 10.1016/j.parint.2005.11.017_bib28
  article-title: A proposal to declare neurocysticercosis an international reportable disease
  publication-title: Bull WHO
  contributor:
    fullname: Roman
– volume: 63
  start-page: 1559
  year: 2004
  ident: 10.1016/j.parint.2005.11.017_bib3
  article-title: Neurocysticercosis in the United States: review of an important emerging infection
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000142979.98182.FF
  contributor:
    fullname: Wallin
– volume: 20
  start-page: 347
  year: 2004
  ident: 10.1016/j.parint.2005.11.017_bib18
  article-title: Disease eradication, elimination and control: the need for accurate and consistent usage
  publication-title: Trends Parasitol
  doi: 10.1016/j.pt.2004.06.004
  contributor:
    fullname: Molyneux
– volume: 67
  start-page: 401
  year: 1989
  ident: 10.1016/j.parint.2005.11.017_bib14
  article-title: Operational studies on control of Taenia solium taeniasis/cysticercosis in Ecuador
  publication-title: Bull WHO
  contributor:
    fullname: Cruz
– volume: 10
  start-page: 269
  year: 1972
  ident: 10.1016/j.parint.2005.11.017_bib8
  article-title: Taeniasis and cysticercosis (Taenia saginata)
  publication-title: Adv Parasitol
  doi: 10.1016/S0065-308X(08)60176-1
  contributor:
    fullname: Pawlowski
– volume: 40
  start-page: 1173
  year: 2005
  ident: 10.1016/j.parint.2005.11.017_bib11
  article-title: Nitazoxanide: a new thiazolide antiparasitic agent
  publication-title: Clin Infect Dis
  doi: 10.1086/428839
  contributor:
    fullname: Fox LeAnne
– ident: 10.1016/j.parint.2005.11.017_bib31
– volume: 27
  start-page: 397
  year: 1993
  ident: 10.1016/j.parint.2005.11.017_bib17
  article-title: Potential erradicability of taeniasis and cysticercosis
  publication-title: Rev Bul Pan Am Health Org
  contributor:
    fullname: Schantz
– volume: 87
  start-page: 177
  year: 2003
  ident: 10.1016/j.parint.2005.11.017_bib20
  article-title: The control of human (neuro)cysticercosis: which way forward?
  publication-title: Acta Trop
  doi: 10.1016/S0001-706X(03)00064-0
  contributor:
    fullname: Engels
– volume: 87
  start-page: 149
  year: 2003
  ident: 10.1016/j.parint.2005.11.017_bib30
  article-title: The global campaign against epilepsy in Africa
  publication-title: Acta Trop
  doi: 10.1016/S0001-706X(03)00038-X
  contributor:
    fullname: Diop
– volume: vol. 2
  start-page: 213
  year: 1998
  ident: 10.1016/j.parint.2005.11.017_bib2
  article-title: Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem
  contributor:
    fullname: Schantz
– year: 1983
  ident: 10.1016/j.parint.2005.11.017_bib6
  contributor:
    fullname: Gemmell
– start-page: 411
  year: 2002
  ident: 10.1016/j.parint.2005.11.017_bib19
  article-title: Control of Taenia solium with emphasis on treatment of taeniasis
  contributor:
    fullname: Allan
– volume: 45
  start-page: 27
  year: 1995
  ident: 10.1016/j.parint.2005.11.017_bib5
  article-title: Ethiopian traditional herbal drugs: Part I. Studies on the toxicity and therapeutic activity of local taenicidal medications
  publication-title: J Ethnopharmacol
  doi: 10.1016/0378-8741(94)01191-2
  contributor:
    fullname: Desta
– volume: 341
  start-page: 197
  year: 1993
  ident: 10.1016/j.parint.2005.11.017_bib29
  article-title: Cysticercosis as a major cause of epilepsy in Peru
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)90064-N
  contributor:
    fullname: Garcia
– start-page: 437
  year: 2002
  ident: 10.1016/j.parint.2005.11.017_bib25
  article-title: Use of simulation model to evaluate control programmes against Taenia solium cysticercosis
  contributor:
    fullname: Gonzalez
– volume: 342
  start-page: 748
  year: 1993
  ident: 10.1016/j.parint.2005.11.017_bib13
  article-title: Neurological symptoms in occult neurocysticercosis after a single taeniacidal dose of praziquantel
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)91743-6
  contributor:
    fullname: Flisser
– volume: 15
  start-page: 2517
  year: 2004
  ident: 10.1016/j.parint.2005.11.017_bib12
  article-title: Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2004.03.035
  contributor:
    fullname: Zhang
– volume: 87
  start-page: 137
  year: 2003
  ident: 10.1016/j.parint.2005.11.017_bib21
  article-title: Measures for the prevention and control of Taenia solium taeniosis and cysticercosis
  publication-title: Acta Trop
  doi: 10.1016/S0001-706X(03)00034-2
  contributor:
    fullname: Sarti
– volume: 22
  start-page: 284
  year: 1991
  ident: 10.1016/j.parint.2005.11.017_bib26
  article-title: Control of Taenia solium taeniasis and cysticercosis by focus-oriented chemotherapy of taeniasis
  publication-title: Southeast Asian J Trop Med Public Health
  contributor:
    fullname: Pawlowski
– volume: 35
  start-page: 1221
  year: 2005
  ident: 10.1016/j.parint.2005.11.017_bib27
  article-title: Control of Taenia solium taeniasis/cysticercosis; from research towards implementation
  publication-title: Int J Parasitol
  doi: 10.1016/j.ijpara.2005.07.015
  contributor:
    fullname: Pawlowski
– ident: 10.1016/j.parint.2005.11.017_bib23
– volume: 61
  start-page: 386
  year: 1999
  ident: 10.1016/j.parint.2005.11.017_bib24
  article-title: Prevalence and risk of cysticercosis and taeniasis in an urban population of soldiers and their relatives
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.1999.61.386
  contributor:
    fullname: García-Garcia
– ident: 10.1016/j.parint.2005.11.017_bib4
– start-page: 363
  year: 2002
  ident: 10.1016/j.parint.2005.11.017_bib15
  article-title: Pharmacology of anticysticercal therapy
  contributor:
    fullname: Jung
– volume: 29
  start-page: 1203
  year: 1996
  ident: 10.1016/j.parint.2005.11.017_bib1
  article-title: Magnitude of the disease burden from neurocysticercosis in a developing country
  publication-title: Curr Infect Dis
  doi: 10.1086/313470
  contributor:
    fullname: Bern
SSID ssj0015771
Score 1.9303375
SecondaryResourceType review_article
Snippet Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key...
Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key...
Neurocysticercosis (NC) is a serious public health problem in Taenia solium endemic areas and in some immigrants and international travelers. A key...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage S105
SubjectTerms Animals
Anticestodal Agents - therapeutic use
Chemotherapy
Control measures
Cysticercus
Humans
Neurocysticercosis
Neurocysticercosis - prevention & control
Niclosamide - therapeutic use
Praziquantel - therapeutic use
Taenia
Taenia solium
Taenia solium - drug effects
Taenia solium - growth & development
Taeniasis - drug therapy
Taeniasis - parasitology
Title Role of chemotherapy of taeniasis in prevention of neurocysticercosis
URI https://dx.doi.org/10.1016/j.parint.2005.11.017
https://www.ncbi.nlm.nih.gov/pubmed/16356763
https://search.proquest.com/docview/19435049
https://pubmed.ncbi.nlm.nih.gov/PMC7108384
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50RfAivl0faw9e45om6aZHWZT1ifgA8VLSNsGKtstuPXjxtztpU3VVEDy2SWiYSSffJDPfAOzqVMeCKkUUqpdw3GNIbHxKTEyZManylbK5w-cXweCWn9yJuynoN7kwNqzS2f7aplfW2r3pOml2h1nWvaboXCFaDvdFRVzGp2EGtyNftmDm4Ph0cPFxmSB6zu-SjNgBTQZdFeZla_3lZX24Yuk8q8plv-5QPxHo90DKLzvT0QLMO0jpHdSzXoQpnS_B7H1RHZgvw-FV8aS9wnionmeXb_Vqn0tlA-3G2djLcm_oqJyK3DZVLJfJa1Xoa5QU2GcFbo8Ob_oD4oonkCSgtCRcCMGEoUz3UnQ7hEllEPha25sztp-iHyVirkKpUHw6tqX5Usmp9k2oNYJIzVahlRe5XgcP21OEOQk1acJlHIQGUQt65H4ofcpj1gbSCCwa1hwZURM89hjVArblLgW6GxEKuA29RqrRhK4jNON_jNxplBDhb2DvNlSui5dxhPpnAr2dNqzVKvmciWXgQyuKX51Q1kcHS7A92ZJnDxXRNqIvySTf-Pd8N2Hu88hmC1rl6EVvI4gp4w5M773RDi7V_tXZZcct2XdCV_Ue
link.rule.ids 230,315,783,787,888,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED4VEIIF8aY8M7Ca4thOkxEhUIGWgYeEWCwnsUUQJBUNAwu_nbOTFApISIyJHcW6s8_f2XffAezrVMeCKkUUqpdw3GNIbHxKTEyZManylbK5w4PLoHfLz-_EXQuOm1wYG1ZZ2_7KpjtrXb_p1NLsDLOsc03RuUK0HB0KR1zGp2CGW3yMk_rgfRznQUW39rpCRmz3Jn_OBXnZSn95WR2tWDJPV7fs1_3pJ_78Hkb5ZV86XYSFGlB6R9WYl6Cl82WYvS_ccfkKnFwVT9orjIfKea6zrd7sc6lsmN0oG3lZ7g1rIqcit02O4zJ5c2W-XpIC-6zC7enJzXGP1KUTSBJQWhIUhGDCUKa7KTodwqRhEPha23szdpiiFyVirqJQofB0bAvzpSGn2jeR1gghNVuD6bzI9QZ42J4iyEmoSRMexkFkELOgP-5HoU95zNpAGoHJYcWQIZvQsUdZCdgWuxTobEgUcBu6jVTlhKYlGvE_vtxrlCBxEdibDZXr4nUkUftMoK_ThvVKJZ8jsfx7aEPxrxPKGnew9NqTLXn24Gi2EXuFLOSb_x7vHsz1bgZ92T-7vNiC-c_Dm22YLl9e9Q7CmTLeddP1A9f59GI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+chemotherapy+of+taeniasis+in+prevention+of+neurocysticercosis&rft.jtitle=Parasitology+international&rft.au=Pawlowski%2C+Zbigniew+S&rft.date=2006-01-01&rft.issn=1383-5769&rft.volume=55+Suppl&rft.spage=S105&rft_id=info:doi/10.1016%2Fj.parint.2005.11.017&rft_id=info%3Apmid%2F16356763&rft.externalDocID=16356763
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1383-5769&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1383-5769&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1383-5769&client=summon